Edwards Lifesciences CorporationEWNYSE
Loading
Operating Income ScalingExpanding
Percentile Rank93
3Y CAGR-1.3%
5Y CAGR+4.8%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
-1.3%/yr
vs +11.7%/yr prior
5Y CAGR
+4.8%/yr
Recent deceleration
Acceleration
-13.0pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.64B | +18.7% |
| 2024 | $1.38B | -3.4% |
| 2023 | $1.43B | -16.2% |
| 2022 | $1.70B | +5.7% |
| 2021 | $1.61B | +24.3% |
| 2020 | $1.30B | +8.2% |
| 2019 | $1.20B | +9.7% |
| 2018 | $1.09B | +8.1% |
| 2017 | $1.01B | +23.9% |
| 2016 | $815.50M | - |